Bardet-Biedl syndrome with rheumatic aortic regurgitation.
Mukta
V
V
Tiwari
S
S
Kalirattiname
M
M
D000293:Adolescent; D000779:Anesthetics, Local / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000150:complications / Q000209:etiology* / Q000503:physiopathology; D001241:Aspirin / Q000627:therapeutic use; D020788:Bardet-Biedl Syndrome / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D002443:Ceftriaxone / Q000627:therapeutic use; D004696:Endocarditis / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010406:Penicillins / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000150:complications* / Q000503:physiopathology; D012307:Risk Factors
D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D010975:Platelet Aggregation Inhibitors; D011343:Procaine; D002443:Ceftriaxone; D001241:Aspirin